Quadrant Capital Group’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-337
| Closed | -$3.89K | – | 1995 |
|
|
2025
Q1 | $3.89K | Buy |
+337
| New | +$3.89K | ﹤0.01% | 2405 |
|
|
2024
Q2 | – | Sell |
-81
| Closed | -$961 | – | 2741 |
|
|
2024
Q1 | $961 | Buy |
+81
| New | +$961 | ﹤0.01% | 2591 |
|
|
2022
Q4 | – | Sell |
-27
| Closed | – | – | 2796 |
|
|
2022
Q3 | $0 | Sell |
27
-8
| -23% | – | ﹤0.01% | 2720 |
|
|
2022
Q2 | $0 | Hold |
35
| – | – | ﹤0.01% | 2634 |
|
|
2022
Q1 | $1K | Hold |
35
| – | – | ﹤0.01% | 2322 |
|
|
2021
Q4 | $0 | Hold |
35
| – | – | ﹤0.01% | 2605 |
|
|
2021
Q3 | $1K | Hold |
35
| – | – | ﹤0.01% | 2328 |
|
|
2021
Q2 | $1K | Hold |
35
| – | – | ﹤0.01% | 2285 |
|
|
2021
Q1 | $1K | Hold |
35
| – | – | ﹤0.01% | 2235 |
|
|
2020
Q4 | $1K | Hold |
35
| – | – | ﹤0.01% | 2135 |
|
|
2020
Q3 | $0 | Buy |
+35
| New | – | ﹤0.01% | 2239 |
|